920
Views
16
CrossRef citations to date
0
Altmetric
Reviews

An update on dry eye disease molecular treatment: advances in drug pipelines

, MBA, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Candela Rodríguez-Pomar, Jesus Pintor, Basilio Colligris & Gonzalo Carracedo. (2017) Therapeutic inhibitors for the treatment of dry eye syndrome. Expert Opinion on Pharmacotherapy 18:17, pages 1855-1865.
Read now
Marcella Nebbioso, Valeria Fameli, Magda Gharbiya, Marta Sacchetti, Anna Maria Zicari & Alessandro Lambiase. (2016) Investigational drugs in dry eye disease. Expert Opinion on Investigational Drugs 25:12, pages 1437-1446.
Read now

Articles from other publishers (14)

Run Bai, Li-ping Liu, Zhen Chen & Qiong Ma. (2022) Cyclosporine (0.05%) Combined with Diclofenac Sodium Eye Drops for the Treatment of Dry Eye Disease. Journal of Ophthalmology 2022, pages 1-6.
Crossref
Francisco Javier Navarro-Gil, Fernando Huete-Toral, Carmen Olalla Domínguez-Godínez, Gonzalo Carracedo & Almudena Crooke. (2022) Contact Lenses Loaded with Melatonin Analogs: A Promising Therapeutic Tool against Dry Eye Disease. Journal of Clinical Medicine 11:12, pages 3483.
Crossref
Danni Qu, Xiangming Tian, Ling Ding, Yuan Li & Wenhui Zhou. (2021) Impacts of Cyclosporin A on clinical pregnancy outcomes of patients with a history of unexplained transfer failure: a retrospective cohort study. Reproductive Biology and Endocrinology 19:1.
Crossref
Sara-Viviana Angulo-Sánchez & David-Alejandro Ortiz-Avila. (2020) Biomarcadores para la evaluación y diagnóstico del síndrome de ojo seco: una revisión. Revista de la Universidad Industrial de Santander. Salud 52:2, pages 89-99.
Crossref
Yu-Jia Li, Li-Jyuan Luo, Scott G. Harroun, Shih-Chun Wei, Binesh Unnikrishnan, Huan-Tsung Chang, Yu-Fen Huang, Jui-Yang Lai & Chih-Ching Huang. (2019) Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease. Nanoscale 11:12, pages 5580-5594.
Crossref
Laurie Barber, Omid Khodai, Thomas Croley, Christopher Lievens, Stephen Montaquila, Jillian Ziemanski, Melissa McCart, Orsolya Lunacsek, Caroline Burk & Vaishali Patel. (2018) Dry eye symptoms and impact on vision-related function across International Task Force guidelines severity levels in the United States. BMC Ophthalmology 18:1.
Crossref
Janine A. Clayton. (2018) Dry Eye. New England Journal of Medicine 378:23, pages 2212-2223.
Crossref
Sujit Kootala, Luimar Filho, Vaibhav Srivastava, Victoria Linderberg, Amani Moussa, Laurent David, Stéphane Trombotto & Thomas Crouzier. (2018) Reinforcing Mucus Barrier Properties with Low Molar Mass Chitosans. Biomacromolecules 19:3, pages 872-882.
Crossref
Xiaobo Zhang, Vimalin Jeyalatha M, Yangluowa Qu, Xin He, Shangkun Ou, Jinghua Bu, Changkai Jia, Junqi Wang, Han Wu, Zuguo Liu & Wei Li. (2017) Dry Eye Management: Targeting the Ocular Surface Microenvironment. International Journal of Molecular Sciences 18:7, pages 1398.
Crossref
Céline Portal, Valérie Gouyer, Frédéric Gottrand & Jean-Luc Desseyn. (2017) Preclinical mouse model to monitor live Muc5b-producing conjunctival goblet cell density under pharmacological treatments. PLOS ONE 12:3, pages e0174764.
Crossref
A. Labbé, C. Baudouin, D. Ismail, M. Amrane, J.-S. Garrigue, A. Leonardi, F.C. Figueiredo, G. Van Setten & M. Labetoulle. (2017) Pan-European survey of the topical ocular use of cyclosporine A. Journal Français d'Ophtalmologie 40:3, pages 187-195.
Crossref
Jaleh Barar, Ayuob Aghanejad, Marziyeh Fathi & Yadollah Omidi. (2016) Advanced drug delivery and targeting technologies for the ocular diseases. BioImpacts 6:1, pages 49-67.
Crossref
Adam R. Thode & Robert A. Latkany. (2015) Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD). Drugs 75:11, pages 1177-1185.
Crossref
Maria Rosaria De Pascale, Michele Lanza, Linda Sommese & Claudio Napoli. (2015) Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis. Journal of Ophthalmology 2015, pages 1-14.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.